Per-Theater Average: What the Metric Reveals About Films

You see a movie grossed $50 million. Sounds huge, right? But if that money came from 4,000 screens, it’s actually pretty weak. If it came from just 200 screens, it’s a blockbuster in the making. This is where Per-Theater Average, often abbreviated as PTA, becomes the most honest metric in Hollywood. It strips away the noise of screen count and tells you how much demand exists for a specific title on a single screen.

Most casual viewers look at total domestic gross. Studio executives look at per-theater averages. Why? Because PTA predicts longevity. A high average means people are actively seeking out the film, not just grabbing tickets because it was the only option playing nearby. Understanding this number helps you separate genuine hits from marketing-driven blips.

What Is Per-Theater Average?

At its core, Per-Theater Average is a calculation that divides a film's total box office revenue by the number of theaters showing it during a specific period. The formula is simple: Total Gross ÷ Number of Theaters = PTA. While it sounds basic, the implications are massive for understanding audience behavior.

For example, if Movie A earns $100,000 across 100 theaters, its PTA is $1,000. If Movie B earns $100,000 across 10 theaters, its PTA is $10,000. Movie B is performing ten times better on a per-screen basis. This doesn't mean Movie B made more money overall, but it signals that its audience density is significantly higher.

This metric is primarily tracked by industry publications like Box Office Mojo and Deadline. They report these numbers weekly, usually on Sundays after weekend grosses are finalized. For investors and analysts, PTA is a leading indicator of whether a wide expansion will pay off or flop.

Why Screen Count Matters More Than You Think

Hollywood distribution strategies generally fall into two buckets: wide releases and limited releases. A wide release puts a film on thousands of screens simultaneously, aiming for maximum visibility. A limited release starts small-often in major cities like New York and Los Angeles-to build word-of-mouth before expanding.

PTA behaves differently in each scenario. In a wide release, a healthy opening weekend PTA for a major studio tentpole might range between $3,000 and $6,000. Anything below $2,000 suggests the marketing didn’t convert to ticket sales efficiently. Conversely, in a limited release, PTAs can skyrocket to $20,000 or even $50,000+ because the films are playing in only one or two premium locations with high foot traffic.

The "Drop-Off" Signal: Predicting Longevity

Here is the secret sauce: watch the second weekend. Studios spend millions on marketing to get people through the doors on Friday. But do they stay interested? If a film’s PTA drops less than 50% from its first weekend to its second, it has strong legs. That means people are telling their friends. This is known as positive word-of-mouth.

Take the animated hit Inside Out 2 in 2024. Its initial PTA was incredibly high, and its drop-off was minimal compared to typical franchise sequels. This signaled that families were returning repeatedly. Contrast that with many superhero films post-2023, which often saw steep PTA declines because audiences burned through them quickly without recommending them enthusiastically.

If you’re trying to guess if a movie will be a long-term earner, look at the percentage change in PTA. A 60% drop is standard for front-loaded action movies. A 30% drop is exceptional. A 70%+ drop usually means the film is dead in the water and theaters will pull it down to make room for new releases within two weeks.

How Distribution Deals Skew the Numbers

Not all theaters are created equal. A multiplex in a dense urban area like Manhattan generates different revenue than a rural cinema in Iowa. When calculating PTA, the geographic spread matters. Some studios use "four-wall" deals, where they rent the screens themselves rather than sharing revenue with the theater chain. This artificially inflates the reported gross because the studio pays the theater regardless of ticket sales, but it allows them to claim a higher PTA for prestige purposes.

Also, consider the type of screens. IMAX and Dolby Cinema screens command higher ticket prices ($18-$25 vs. $12-$15 for standard). A film with a high percentage of premium format screens will naturally have a higher PTA, even if attendance is identical. Analysts adjust for this by looking at "premium format share," but raw PTA doesn't always account for it. Always check if the high average is driven by expensive tickets or packed seats.

Case Study: Limited Release Success Stories

Let’s look at real-world examples to ground this theory. Consider Everything Everywhere All At Once. It started in just three theaters. Its opening weekend PTA was over $30,000. This wasn't just luck; it was a signal to distributors that the film had viral potential. As they expanded to 500 theaters, the PTA remained robust, eventually leading to a massive $140 million global haul.

Now compare that to a typical horror sequel. Many horror franchises open wide immediately. They might get a $4,000 PTA. That looks okay on paper, but because they opened on 3,000 screens, the total gross is high ($12 million). However, the low PTA indicates that the hype was broad but shallow. These films rarely sustain interest beyond three weekends.

Another interesting case is Oppenheimer. Despite being a three-hour historical drama, its PTA remained remarkably stable throughout its run. This defied conventional wisdom that long films lose steam quickly. The high PTA proved that the audience commitment was deep, not just a curiosity spike.

Common Pitfalls When Reading Box Office Data

Don't take PTA at face value. Here are three traps to avoid:

• The Holiday Effect: During Thanksgiving or Christmas, PTAs naturally rise because more people go to the movies. A $5,000 PTA in July is impressive; in December, it’s mediocre. Always compare year-over-year during the same holiday window.
• Screen Shrinking: Sometimes, a film’s total gross stays flat while screen counts drop drastically. This makes the PTA look like it’s rising, but it’s actually a sign of contraction. Theaters are cutting bad shows, leaving only the best-performing slots. This is called "screen optimization," not growth.
• International Variance: PTA standards differ globally. A $2,000 PTA in China might be excellent due to lower ticket prices, whereas in the US, it’s poor. Never compare US PTAs directly with international ones without adjusting for currency and local pricing structures.

Why Investors Care More Than Fans

Fans care about total gross because it feeds ego. "My favorite movie made $500 million!" Investors care about PTA because it dictates future spending. If a director’s last three films had declining PTAs, studios will hesitate to give them a $200 million budget next time. High PTA reduces risk. It proves the filmmaker can draw crowds efficiently.

This is why indie darlings often get bigger budgets despite smaller total grosses. Their high PTAs show efficiency. They deliver more revenue per dollar spent on screens. For a studio, a film with a $10,000 PTA on 100 screens is often more profitable than a film with a $1,000 PTA on 1,000 screens, because the latter requires massive marketing spend to fill those extra seats.

Next Steps: How to Track This Yourself

You don’t need a Bloomberg terminal to track this. Sites like Box Office Mojo and The Numbers publish daily and weekend updates. Here’s your checklist for analyzing any new release:

1. Check the Opening Weekend PTA: Is it above $3,000 for a wide release? Above $15,000 for a limited release?
2. Wait for Week 2: Calculate the percentage drop. Under 50% is good. Over 60% is worrying.
3. Look at Screen Changes: Did theaters add or remove screens? Adding screens while maintaining PTA is a bullish sign.
4. Compare to Genre Benchmarks: Horror films have different norms than musicals. Don’t judge a horror movie by superhero standards.

By focusing on per-theater averages, you stop guessing and start understanding the actual health of a film’s commercial life. It’s the difference between hearing a rumor and reading the medical chart.